What was recalled
The U.S. Food and Drug Administration has announced a significant Class I recall involving specific medical products distributed by Medline Industries, LP. This action centers on the "Medline Convenience Kits," specifically identified as the KIT ANESTHESIA L&D A-LINE SET. It is important to understand exactly what this product is: it is a specialized bundle of supplies designed for use in labor and delivery settings, likely intended to streamline the process for medical professionals administering anesthesia or managing arterial lines during childbirth. The recall does not apply to every item Medline sells, nor even to every kit with a similar name. It is strictly limited to specific lots of this particular catalog number, distributed nationwide within the United States.
The precise identifiers for the recalled items are critical for anyone checking their inventory. The product in question carries the Catalog Number DYKMBNDL199A. To ensure accuracy, the recall notice provides specific Unique Device Identifiers (UDI-DI) and Lot Numbers that must be matched exactly. Each individual kit is associated with the UDI-DI 10193489848540, while the case packaging bears the UDI-DI 40193489848541. The recall targets three distinct lot numbers: 24HBH109, 24HBM182, and 24HBS365. If a healthcare facility or individual possesses kits with these specific lot codes, they are part of this recall. The notice does not specify the total number of units involved in this distribution, but it confirms that the scope of the issue is nationwide, meaning these kits may be located in hospitals, clinics, or medical supply stores across all fifty states.
The timing of this recall is also a key detail for tracking the affected products. The official recall date is listed as August 11, 2026. This means that Medline Industries, LP initiated this corrective action on that date, notifying regulatory bodies and potentially downstream customers. For healthcare providers reviewing their stock, it is essential to check not just the catalog number but also the expiration or manufacturing dates associated with the specific lot numbers mentioned above. The distribution pattern indicates that these items were sold throughout the entire United States, so geographic location does not limit the potential presence of these kits. If you are working in obstetrics, anesthesia, or related fields in Illinois or any other state, and you use Medline convenience kits for line sets, verifying these specific codes against your current inventory is the first step in ensuring patient safety.
This classification as a Class I recall by the FDA underscores the seriousness of the situation. Class I recalls are reserved for situations where there is a reasonable probability that the use of the product will cause serious adverse health consequences or death. By recalling these specific Medline Convenience Kits, the agency and the manufacturer are acting to prevent potential harm before it occurs. The focus remains entirely on the identification of the correct products: DYKMBNDL199A kits with lots 24HBH109, 24HBM182, or 24HBS365. Any other Medline products, even those in the same convenience kit line but with different lot numbers or catalog codes, are not included in this specific recall notice. It is vital to rely on these exact details when conducting an inventory check.
The hazard, explained
When we talk about a Class I recall from the FDA, we are discussing the most serious category of safety alert. This classification is reserved for situations where exposure to the defective product is likely to cause serious adverse health consequences or death. In this specific case involving Medline Industries, LP, the issue centers on sterile applicators contained within the "KIT ANESTHESIA L&D A-LINE SET" (Catalog Number DYKMBNDL199A). The physical failure here is not mechanical, like a broken valve or a cracked tube, but biological. The recall notice indicates that certain lots of these sterilized kits may have been compromised by fungal contamination, specifically a type of fungus known as Aspergillus penicillioides. To understand why this is so dangerous, we need to look at how sterile medical supplies are supposed to work and what happens when that barrier fails.
Sterile applicators are designed to be completely free of living organisms. They are packaged and processed in a way that ensures they do not carry bacteria, viruses, or fungi until the moment they are opened for use. This sterility is critical because these kits are used in sensitive medical environments, such as labor and delivery units, where patients may have compromised immune systems or open wounds. The hazard arises when environmental conditions during manufacturing, storage, or transport allow fungal spores to survive the sterilization process or to penetrate the packaging. Once inside the kit, if the environment is right, these spores can grow into Aspergillus penicillioides. This fungus is not just a surface mold; it is an invasive pathogen that can thrive in medical settings.
The mechanism of harm occurs when a healthcare provider uses one of these contaminated applicators on a patient. Because the kit is intended for anesthesia and line setup, it likely comes into contact with vascular access points or sensitive tissue areas. When Aspergillus penicillioides is introduced to the body through such a route, it does not behave like a typical skin irritant. Instead, it can invade deeper tissues and enter the bloodstream. For healthy individuals, the immune system might handle a minor exposure, but for patients who are already vulnerable—such as those undergoing surgery, new mothers in postpartum care, or individuals with weakened immune defenses—the consequences can be rapid and severe. The fungus can trigger systemic infections, where the infection spreads throughout the body via the blood, leading to sepsis. Sepsis is a life-threatening reaction to an infection that causes widespread inflammation and organ failure. In the worst-case scenarios documented in medical literature regarding invasive aspergillosis, this can lead to critical illness and even death. The danger lies in the fact that the contamination is invisible; the applicator may look perfectly clean and sterile to the naked eye, but it is carrying a microscopic biological threat ready to cause significant harm upon contact.
Who is most at risk
To understand who is truly vulnerable in this recall, we first need to look at the specific context of the product involved. The Medline Convenience Kit identified in this FDA notice is not a household item or a general-purpose supply. It is specifically cataloged as an "Anesthesia L&D A-Line Set," which stands for Labor and Delivery. This detail is critical because it immediately narrows the scope of who handles these kits: healthcare professionals in obstetrics, anesthesiology, and related medical fields. Consequently, the primary group at immediate risk from handling or using these contaminated kits are the patients undergoing labor and delivery procedures, as well as the medical staff administering anesthesia.
The hazard stems from sterile applicators within the kit that may harbor Aspergillus penicillioides, a type of fungus. While this fungus is common in the environment, it becomes dangerous when introduced directly into the body through compromised skin barriers or mucous membranes. For healthy adults with robust immune systems, incidental exposure might result in minor irritation or no reaction at all. However, the patients for whom these kits are intended—women in labor and their newborns—are physiologically distinct groups that require careful consideration regarding infection risk.
Newborn infants represent one of the most vulnerable populations in any medical setting. Their immune systems are still developing and have not yet built up the defenses required to fight off opportunistic pathogens like fungi. If a contaminated applicator is used for skin preparation or cleaning near a newborn, even a small amount of fungal contamination can bypass their natural barriers. Because infants have limited physiological reserve, an infection that might be manageable in an adult can progress rapidly to systemic illness or sepsis in a neonate. Sepsis, a life-threatening response to infection, is particularly dangerous for newborns because their bodies cannot regulate the inflammatory response as effectively as adults.
Pregnant individuals are also at heightened risk during this specific medical event. Labor and delivery involve significant physical stress on the body, including potential tears, episiotomies, or other breaks in the skin integrity. These openings provide a direct pathway for pathogens to enter the bloodstream. Furthermore, pregnancy naturally alters the immune system to protect the fetus, which can sometimes make the mother more susceptible to certain infections or change how her body responds to them. The FDA’s classification of this recall as Class I indicates that using the product could cause serious adverse health consequences, including death, underscoring the severity of this vulnerability.
While the general public is not at risk because these kits are distributed exclusively through medical channels for professional use, healthcare workers who handle these items are also indirectly at risk. Although their primary concern is patient safety, improper handling of contaminated sterile supplies can lead to cross-contamination within the operating room or delivery suite, potentially affecting other immunocompromised patients in the same facility. Therefore, the circle of risk centers tightly on the clinical environment where anesthesia and labor services are provided.
How to tell if you have the recalled item
Verifying whether a medical device is part of an official recall requires precise attention to detail. In the case of this FDA Class I recall involving Medline Industries, LP, the identification process is not about guessing or relying on general descriptions. It depends entirely on matching specific alphanumeric codes printed directly on the product packaging and labels. Because these kits are distributed nationwide in Illinois and across the United States, they may appear in various healthcare settings, clinics, or supply rooms, making it crucial to inspect the physical items rather than relying on memory of where you purchased them.
The primary object of concern is the Medline Convenience Kit, specifically identified as the "KIT ANESTHESIA L&D A-LINE SET." If you are looking at a box or package, start by locating the catalog number. The recalled item will clearly display the catalog number DYKMBNDL199A. This code is your first major filter; if your kit has a different catalog number, it is not part of this specific recall action. Alongside the catalog number, you must check for the Unique Device Identifier (UDI-DI). For this recall, the UDI-DI associated with each individual unit is 10193489848540, and the UDI-DI for the case is 40193489848541. These numbers are typically found on the barcode label or the front panel of the sterile packaging.
However, the catalog and UDI numbers alone do not confirm that your specific unit is defective. The recall targets only certain lots of sterile applicators within these kits that may contain fungal contamination by Aspergillus penicillioides. Therefore, you must locate the lot number printed on the packaging. There are exactly three lot numbers currently identified in this recall action. You need to check your kit against this specific list:
- Lot Number 24HBH109
- Lot Number 24HBM182
- Lot Number 24HBS365
If the lot number on your Medline Convenience Kit matches one of these three codes, and the catalog number is DYKMBNDL199A, you have a recalled item. If the lot number does not match any of these, or if the catalog number is different, your product is not affected by this specific safety alert. It is important to look closely at the print on the box, as lot numbers can sometimes be small or printed in contrasting colors. Take a moment to verify both the catalog number and the lot number against the official list above before taking any further action.
What to do — step by step
When you receive news of a Class I medical device recall, such as the one involving Medline Convenience Kits, it is natural to feel overwhelmed or anxious. However, taking immediate, methodical action is the most effective way to protect your health and ensure the process is handled correctly. Because this specific recall involves sterile applicators potentially contaminated with Aspergillus penicillioides, a fungus that can cause serious systemic infections, sepsis, or even death in vulnerable individuals, you must treat any potential exposure with utmost seriousness. The following steps are designed to guide you through the immediate response, verification, and resolution process.
Step 1: Stop Using the Product Immediately
If you are a healthcare provider, patient, or caregiver who possesses the recalled Medline Convenience Kit (specifically the KIT ANESTHESIA L&D A-LINE SET with Catalog Number DYKMBNDL199A), cease use of the sterile applicators inside right away. Do not attempt to inspect the contents for visible signs of contamination, as fungal growth may not be visible to the naked eye and handling them could expose you or others to harmful spores. Place the entire kit in a secure location away from active clinical areas or patient care zones to prevent accidental use by other staff or individuals. This immediate cessation is critical because the hazard lies in the invisible biological risk, not in mechanical failure.
Step 2: Verify Your Inventory Against the Recall Details
To determine if your specific items are affected, you must carefully check the lot numbers and Universal Device Identification (UDI) codes on your packaging. The FDA recall applies only to three specific lots of the DYKMBNDL199A catalog number: Lot 24HBH109, Lot 24HBM182, and Lot 24HBS365. Check both the individual unit UDI-DI (10193489848540) and the case UDI-DI (40193489848541). If your inventory matches these identifiers, you are holding a recalled product. If it does not, your supplies are safe to use, but it is good practice to document this verification for your records.
Step 3: Contact Medline Industries for Disposition Instructions
The official FDA recall notice does not explicitly state whether you should return the items, destroy them, or request a refund directly through a specific portal. Therefore, the most crucial next step is to contact Medline Industries, LP, directly to obtain precise instructions on how to dispose of or return the contaminated kits. Healthcare facilities should notify their procurement department and compliance officer immediately so they can coordinate with the manufacturer. Follow the manufacturer’s guidance strictly for returning or destroying the units to ensure regulatory compliance and personal safety.
Step 4: Monitor for Health Concerns
If any of these applicators have already been used on a patient, notify the relevant medical staff immediately. Although no incidents or injuries are reported in this recall data, the potential for serious adverse health consequences exists. Patients who may have been exposed should be monitored for signs of infection, such as fever, redness at the site, or systemic illness, and healthcare providers should be alerted to consider fungal infections in their differential diagnosis if symptoms arise.
Step 5: Report Adverse Events
If you suspect that the recalled product caused harm, or even if no harm occurred but you wish to report the quality issue, you can submit a mandatory report to the FDA’s MedWatch program. This helps authorities track the scope of the contamination and protect other patients nationwide.
Your refund, repair, or replacement options
When you encounter a medical device recall, the immediate question is almost always about restitution: How do I get my money back, and how do I replace this critical item? In the case of the Medline Industries, LP recall regarding the Medline Convenience Kits (specifically the KIT ANESTHESIA L&D A-LINE SET with catalog number DYKMBNDL199A), it is important to approach this situation with clarity and patience. The official FDA recall documentation for this Class I device, dated August 11, 2026, does not explicitly list a standardized remedy such as a direct refund portal, a prepaid return label, or a specific repair protocol within the public hazard record. This absence of stated remediation details in the initial report is not uncommon in certain types of medical device recalls, particularly those involving Class I devices where the primary regulatory focus is on immediate cessation of use and containment of the hazard rather than a complex consumer reimbursement process.
However, the lack of a published remedy in the general alert does not mean you have no recourse. It simply means you must take the next step to initiate contact directly with the manufacturer or your healthcare provider. Medline Industries, LP is a major distributor of medical supplies, and they maintain robust customer service channels for managing distribution issues, even when the specific recall notice has not yet detailed the financial logistics. If you are a consumer who purchased these kits directly, your first logical step is to locate your original proof of purchase. Whether this is a digital receipt, a credit card statement, or a physical invoice from a hospital supply vendor, having this documentation ready will be essential when you reach out to Medline’s customer support team.
If you are a healthcare facility that received these kits through institutional distribution, the process is slightly different. You should immediately contact your hospital’s supply chain department or procurement officer. They will likely have a direct line to Medline’s corporate accounts representative who can coordinate the return of the affected lots (24HBH109, 24HBM182, and 24HBS365) and arrange for replacement stock or credit memos. Healthcare providers are accustomed to handling Class I recalls efficiently, as patient safety is the paramount concern. They will typically quarantine the contaminated sterile applicators containing potential Aspergillus penicillioides contamination rather than attempting to "repair" them, which is impossible for sterile medical devices.
For individual consumers or smaller clinics, you should call Medline’s general customer service line. While the specific phone number is not listed in the hazard summary, it can be found on the Medline website or your product packaging. When you contact them, clearly state that you have a unit with UDI-DI 10193489848540 and one of the three affected lot numbers. Ask specifically about their current protocol for this recall: do they offer a full refund, store credit, or a direct replacement with a non-contaminated batch? Do not assume the remedy is automatic; you must advocate for yourself by asking these questions directly. This proactive approach ensures that you are not left holding a potentially dangerous medical supply and that you receive appropriate compensation for the inconvenience and risk involved.
It is also worth noting that because this recall involves sterile applicators used in anesthesia and labor and delivery settings, the urgency of replacement is high. If you are a patient or caregiver who has already used these kits, your "remedy" is medical monitoring rather than financial restitution. However, for those holding unused inventory, securing a replacement from Medline through direct communication is the only path to resolving the material aspect of this recall. Keep all correspondence with Medline in writing, whether via email or logged phone calls, as this will serve as your record if any disputes arise regarding refunds or replacements later on.
What can happen if you ignore it
When a medical device carries a Class I recall designation from the FDA, it signals the most serious level of potential danger. This classification is reserved for situations where exposure to the recalled product is likely to cause serious adverse health consequences or death. In the case of the Medline Convenience Kits containing the Anesthesia L&D A-Line Set (Catalog Number DYKMBNDL199A), ignoring this recall is not merely a matter of administrative inconvenience; it is a direct threat to patient and provider safety. The core issue lies in the sterile applicators included within these kits, which may harbor fungal contamination specifically identified as Aspergillus penicillioides. This fungus can grow under certain environmental conditions, compromising the sterility that is critical for any item intended for clinical use.
If you continue to use these contaminated kits, the primary risk is the introduction of a pathogenic organism into a patient’s body. Because these kits are designed for anesthesia and labor and delivery procedures, they are often used in settings where patients may already be vulnerable due to surgery, childbirth, or underlying health conditions. The skin preparation products within the kit are meant to clean and protect the site, but if those products are contaminated with Aspergillus penicillioides, they become a vector for infection rather than a barrier against it. Once this fungus enters the body through breaks in the skin or mucous membranes during these procedures, it can lead to systemic infection. This means the infection spreads throughout the bloodstream and other organs, rather than staying localized at the site of application.
The consequences of such an infection are severe and potentially fatal. Sepsis is a life-threatening response to infection that can trigger widespread inflammation, organ failure, and shock. For patients undergoing anesthesia or labor, their bodies are already under significant physiological stress. Introducing a fungal pathogen into this system can rapidly escalate from a localized issue to a critical emergency. Illness resulting from such contamination may require extensive medical intervention, including antifungal medications, prolonged hospital stays, and intensive care support. In the worst-case scenarios documented in similar medical device recalls, these infections have led to death, particularly in immunocompromised individuals or those with compromised skin barriers.
Furthermore, ignoring the recall disrupts the chain of sterile processing that hospitals and clinics rely on for patient safety protocols. Medical professionals trust that devices labeled as "sterile" are free from viable microorganisms. By using a recalled kit, you are bypassing a critical safety net designed to prevent healthcare-associated infections. There is no way to visually identify the fungal contamination; it may not be apparent to the naked eye until it is too late. Therefore, continuing to use these items undermines the fundamental principles of aseptic technique in medicine. The potential cost is not just financial or logistical, but the irreversible health outcomes for patients who rely on sterile, safe medical supplies during some of the most critical moments of their lives.